These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38494073)

  • 1. The role of extracellular vesicles in non-alcoholic steatohepatitis: Emerging mechanisms, potential therapeutics and biomarkers.
    Wang Q; Tang X; Wang Y; Zhang D; Li X; Liu S
    J Adv Res; 2024 Mar; ():. PubMed ID: 38494073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.
    Zhu Q; Li H; Ao Z; Xu H; Luo J; Kaurich C; Yang R; Zhu PW; Chen SD; Wang XD; Tang LJ; Li G; Huang OY; Zheng MH; Li HP; Liu F
    J Nanobiotechnology; 2022 Jul; 20(1):349. PubMed ID: 35897102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH-Future Horizons in NASH Management.
    Trifylli EM; Kriebardis AG; Koustas E; Papadopoulos N; Deutsch M; Aloizos G; Fortis SP; Papageorgiou EG; Tsagarakis A; Manolakopoulos S
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis.
    Kim J; Lee SK; Jeong SY; Cho HJ; Park J; Kim TM; Kim S
    J Nanobiotechnology; 2021 Nov; 19(1):372. PubMed ID: 34789265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis.
    Povero D; Feldstein AE
    Diabetes Metab J; 2016 Feb; 40(1):1-11. PubMed ID: 26912150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin β
    Guo Q; Furuta K; Lucien F; Gutierrez Sanchez LH; Hirsova P; Krishnan A; Kabashima A; Pavelko KD; Madden B; Alhuwaish H; Gao Y; Revzin A; Ibrahim SH
    J Hepatol; 2019 Dec; 71(6):1193-1205. PubMed ID: 31433301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles in fatty liver disease and steatohepatitis: Role as biomarkers and therapeutic targets.
    Eguchi A; Iwasa M; Nakagawa H
    Liver Int; 2023 Feb; 43(2):292-298. PubMed ID: 36462157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles as Carriers of Non-coding RNAs in Liver Diseases.
    Yang J; Li C; Zhang L; Wang X
    Front Pharmacol; 2018; 9():415. PubMed ID: 29740327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases.
    Eguchi A; Feldstein AE
    Liver Res; 2018 Mar; 2(1):30-34. PubMed ID: 30345152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH).
    Qi X; Lai J
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles in liver disease and beyond.
    Morán L; Cubero FJ
    World J Gastroenterol; 2018 Oct; 24(40):4519-4526. PubMed ID: 30386101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding the Role of Extracellular Vesicles in Liver Diseases.
    Deng F; Magee N; Zhang Y
    Liver Res; 2017 Sep; 1(3):147-155. PubMed ID: 29552373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.
    Dasgupta D; Nakao Y; Mauer AS; Thompson JM; Sehrawat TS; Liao CY; Krishnan A; Lucien F; Guo Q; Liu M; Xue F; Fukushima M; Katsumi T; Bansal A; Pandey MK; Maiers JL; DeGrado T; Ibrahim SH; Revzin A; Pavelko KD; Barry MA; Kaufman RJ; Malhi H
    Gastroenterology; 2020 Oct; 159(4):1487-1503.e17. PubMed ID: 32574624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease.
    Newman LA; Sorich MJ; Rowland A
    J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32610455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles as Biomarkers in Liver Disease.
    Muñoz-Hernández R; Rojas Á; Gato S; Gallego J; Gil-Gómez A; Castro MJ; Ampuero J; Romero-Gómez M
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLSC-Derived Extracellular Vesicles Attenuate Liver Fibrosis and Inflammation in a Murine Model of Non-alcoholic Steatohepatitis.
    Bruno S; Pasquino C; Herrera Sanchez MB; Tapparo M; Figliolini F; Grange C; Chiabotto G; Cedrino M; Deregibus MC; Tetta C; Camussi G
    Mol Ther; 2020 Feb; 28(2):479-489. PubMed ID: 31757759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease.
    Ban LA; Shackel NA; McLennan SV
    Int J Mol Sci; 2016 Mar; 17(3):376. PubMed ID: 26985892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative preconditioning strategies for improving the therapeutic efficacy of extracellular vesicles derived from mesenchymal stem cells in gastrointestinal diseases.
    Didamoony MA; Soubh AA; Atwa AM; Ahmed LA
    Inflammopharmacology; 2023 Dec; 31(6):2973-2993. PubMed ID: 37874430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update.
    Dorairaj V; Sulaiman SA; Abu N; Abdul Murad NA
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis.
    Devhare PB; Ray RB
    Mol Aspects Med; 2018 Apr; 60():115-122. PubMed ID: 29122679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.